A phase III trial to evaulate linaclotide delayed release-1 (DR1) in adult patients with IBS-C
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 02 Nov 2017 According to an Ironwood Pharmaceuticals media release, this trial is expected to begin in 2018.
- 15 May 2017 New trial record
- 08 May 2017 This trial is expected to begin in the second half of 2017, according to an Ironwood Pharmaceuticals media release.